Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.

Dubinsky, Samuel

Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Sep 2019 - 3209-3217 p. digital

Publication Type: Journal Article; Review

1433-7339

10.1007/s00520-019-04816-y doi


Androstenes--adverse effects
Anticoagulants--adverse effects
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Disease Progression
Drug Interactions
Humans
Male
Prednisone--therapeutic use
Prostatic Neoplasms, Castration-Resistant--blood
Quality of Life
Retrospective Studies
Thrombosis--drug therapy
Treatment Outcome